CAPTURE OF HUMAN GROUND STATE PLURIPOTENT STEM CELLS

Lead Research Organisation: University of Cambridge
Department Name: Biochemistry

Abstract

Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.

Organisations

Publications

10 25 50

publication icon
Moretti A (2010) Mouse and human induced pluripotent stem cells as a source for multipotent Isl1+ cardiovascular progenitors. in FASEB journal : official publication of the Federation of American Societies for Experimental Biology

publication icon
Roode M (2012) Human hypoblast formation is not dependent on FGF signalling. in Developmental biology

publication icon
Rostovskaya M (2015) Towards consistent generation of pancreatic lineage progenitors from human pluripotent stem cells. in Philosophical transactions of the Royal Society of London. Series B, Biological sciences

publication icon
Smith A (2013) Nanog heterogeneity: tilting at windmills? in Cell stem cell

publication icon
Tailor J (2013) Stem cells expanded from the human embryonic hindbrain stably retain regional specification and high neurogenic potency. in The Journal of neuroscience : the official journal of the Society for Neuroscience

 
Title Stem Cell Revolutions 
Description Austin Smith provided the voice over for the Stem Cell Revolutions film. Featuring beautiful hand-drawn animations and interviews with leading stem cell scientists, Stem Cell Revolutions charts the history and scientific evolution of stem cell research - from the earliest experiments that first revealed stem cells in the body, to leading current scientific and clinical developments 
Type Of Art Film/Video/Animation 
Year Produced 2013 
Impact Increased understanding of Stem Cell Biology on an international scale 
URL http://www.stemcellrevolutions.com/watch
 
Description Academy of Medical Sciences Report on Embryo Research and Chimaeras
Geographic Reach National 
Policy Influence Type Participation in a national consultation
 
Description Advisory board member for: Izmir Biomedicine and Genome Center, Dokuz Eylul University, Turkey
Geographic Reach Europe 
Policy Influence Type Participation in a advisory committee
 
Description AstraZeneca, Stem Cell & Primary Cell Scientific Advisory Board, Sweden
Geographic Reach Europe 
Policy Influence Type Participation in a advisory committee
 
Description Briefing of Policy Advisor
Geographic Reach National 
Policy Influence Type Participation in a national consultation
 
Description Briefing of Wellcome Trust Policy Advisor
Geographic Reach National 
Policy Influence Type Participation in a advisory committee
 
Description Briefing of Wellcome Trust Policy Advisor - Dr Alexis Gilbert
Geographic Reach National 
Policy Influence Type Participation in a advisory committee
 
Description CDB
Geographic Reach Multiple continents/international 
Policy Influence Type Participation in advisory committee
 
Description Cell Fate and Cancer Programme, Centre for Genomic Regulation, Barcelona, Spain
Geographic Reach Europe 
Policy Influence Type Participation in a advisory committee
 
Description Cell Therapy Catapult Academic Advisory Board, London, UK
Geographic Reach Europe 
Policy Influence Type Participation in a advisory committee
 
Description CiRA Symposium, Kyoto
Geographic Reach Europe 
Policy Influence Type Influenced training of practitioners or researchers
 
Description CiRA Symposium, Kyoto
Geographic Reach Multiple continents/international 
Policy Influence Type Influenced training of practitioners or researchers
 
Description EMBO Advisory Board Meeting
Geographic Reach Europe 
Policy Influence Type Participation in advisory committee
 
Description EMBO Membership Committee
Geographic Reach Europe 
Policy Influence Type Membership of a guidance committee
 
Description EMBO Science and Society Report on Stem Cell Research
Geographic Reach Europe 
Policy Influence Type Citation in other policy documents
 
Description Erasmus University Medical Centre, Stem Cell Initiative for Regenerative Medicine, international External Scientific Advisory Board
Geographic Reach Europe 
Policy Influence Type Participation in advisory committee
 
Description European Court of Justice decision on patents on Embryonic stem cell research
Geographic Reach Europe 
Policy Influence Type Participation in a national consultation
 
Description G-COE Advisory Board
Geographic Reach Asia 
Policy Influence Type Participation in advisory committee
 
Description Global COE programme, Kyoto
Geographic Reach Multiple continents/international 
Policy Influence Type Participation in advisory committee
 
Description House of Commons Science and Technology Committee Consultation
Geographic Reach National 
Policy Influence Type Gave evidence to a government review
 
Description Hubrecht Institute International Eveluation Committee
Geographic Reach Multiple continents/international 
Policy Influence Type Membership of a guidance committee
 
Description ISAB Meeting
Geographic Reach Multiple continents/international 
Policy Influence Type Participation in advisory committee
 
Description ISSCR - keynote speaker
Geographic Reach Multiple continents/international 
Policy Influence Type Influenced training of practitioners or researchers
 
Description ISSCR Advisory Board
Geographic Reach Multiple continents/international 
Policy Influence Type Participation in advisory committee
 
Description ISSCR Board of Directors Meeting
Geographic Reach Multiple continents/international 
Policy Influence Type Participation in advisory committee
 
Description International Scientific Advisory Board Annual Meeting 2014
Geographic Reach Multiple continents/international 
Policy Influence Type Participation in advisory committee
 
Description MEP Briefing
Geographic Reach Europe 
Policy Influence Type Influenced training of practitioners or researchers
 
Description MEP Forum - Brussels
Geographic Reach Europe 
Policy Influence Type Participation in a national consultation
 
Description MRC-Chinese Academy of Sciences Workshop
Geographic Reach Asia 
Policy Influence Type Participation in advisory committee
 
Description Meeting with iPS Cell Surveillance Project, Japan Science and Technology Agency
Geographic Reach Asia 
Policy Influence Type Membership of a guidance committee
 
Description OICR Cancer Stem Cell Program, Scientific Advisory Board
Geographic Reach North America 
Policy Influence Type Participation in advisory committee
 
Description Pontifical Academy of Sciences
Geographic Reach Europe 
Policy Influence Type Participation in advisory committee
 
Description REVIVE Stem Cell Network
Geographic Reach Europe 
Policy Influence Type Participation in advisory committee
 
Description RIKEN Advisory Council
Geographic Reach Asia 
Policy Influence Type Participation in advisory committee
 
Description Riken Advisory Council
Geographic Reach Europe 
Policy Influence Type Participation in advisory committee
 
Description Science Foundation Ireland, REMEDEI CSET Site Visit
Geographic Reach Europe 
Policy Influence Type Participation in advisory committee
 
Description UK Stem Cell Bank Management Committee
Geographic Reach National 
Policy Influence Type Participation in advisory committee
 
Description UKRMP Advisory Board
Geographic Reach National 
Policy Influence Type Participation in advisory committee
 
Description UKSCB Advisory Board
Geographic Reach National 
Policy Influence Type Participation in advisory committee
 
Description University of Lund BMC Scientific Advisory Council
Geographic Reach Europe 
Policy Influence Type Participation in advisory committee
 
Description Wellcome Trust Meeting - Embryonic Stem Cell Research:Beyond Brustle v Greenpeace
Geographic Reach Multiple continents/international 
Policy Influence Type Participation in advisory committee
 
Description Wellcome Trust Sanger Institute Cellular Genetics Programme
Geographic Reach Europe 
Policy Influence Type Participation in a advisory committee
 
Description Addenbrookes Charitable Trust award of Consumables for Dr. K.Kurian to work within Biochemistry: Stem Cell Institute
Amount £10,000 (GBP)
Organisation Addenbrooke's Charitable Trust (ACT) 
Sector Charity/Non Profit
Country United Kingdom
Start  
 
Description BB/H012737/1 Gene Targetting by homologous recombination in the Rat
Amount £612,215 (GBP)
Funding ID BB/H012737/1 
Organisation Biotechnology and Biological Sciences Research Council (BBSRC) 
Sector Public
Country United Kingdom
Start 01/2011 
End 05/2015
 
Description BBSRC Stem Cell Potency
Amount £841,267 (GBP)
Organisation Biotechnology and Biological Sciences Research Council (BBSRC) 
Sector Public
Country United Kingdom
Start 08/2006 
End 02/2008
 
Description Beit Memorial Fellowship for Medical Research
Amount £126,043 (GBP)
Organisation Wellcome Trust 
Department Wellcome-Beit Prize Fellowships
Sector Private
Country United Kingdom
Start 10/2007 
End 09/2010
 
Description BetaCellTherapy: Beta Cell Therapy in Diabetes
Amount £823,424 (GBP)
Organisation European Commission 
Sector Public
Country European Union (EU)
Start 01/2010 
End 12/2014
 
Description Centre for Stem Cell Biology & Regenerative Medicine
Amount £795,134 (GBP)
Organisation Medical Research Council (MRC) 
Sector Academic/University
Country United Kingdom
Start 01/2009 
End 12/2011
 
Description Characterisation of new human ES cell derived in novel
Amount £55,624 (GBP)
Funding ID 4-2005-821 
Organisation Juvenile Diabetes Research Foundation (JDRF) 
Sector Charity/Non Profit
Country United Kingdom
Start 01/2007 
End 12/2007
 
Description Collaborative bursary MiRNA expression in brain cancer stem cells
Amount £6,000 (GBP)
Organisation Cancer Research UK 
Sector Charity/Non Profit
Country United Kingdom
Start  
 
Description Core Support for Wellcome Trust Centre for Stem Cell Research
Amount £6,956,531 (GBP)
Organisation Wellcome Trust 
Sector Charity/Non Profit
Country United Kingdom
Start 01/2007 
End 12/2011
 
Description ESTOOLS: Platforms for Biomedical Discovery with Human ES cells
Amount £373,970 (GBP)
Organisation European Commission 
Sector Public
Country European Union (EU)
Start 08/2006 
End 07/2010
 
Description EURATRANS European large-scale functional genomics in the rat for translational research (10.5m euros across 19 participants)
Amount £517,672 (GBP)
Organisation European Commission 
Sector Public
Country European Union (EU)
Start 04/2010 
End 09/2014
 
Description EUROSTEMCELL: European Consortium for Stem Cell Research (0.8m euros across 11 participants)
Amount £6,457 (GBP)
Organisation European Commission 
Sector Public
Country European Union (EU)
Start 03/2010 
End 02/2015
 
Description EUROSTEMCELL: European Consortium for Stem Cell Research (0.8m euros across 11 participants)
Amount £38,175 (GBP)
Organisation European Commission 
Sector Public
Country European Union (EU)
Start 09/2006 
End 01/2008
 
Description EUROSYSTEM European consortium for systematic stem Cell Biology (12m euros across 24 participants)
Amount £1,184,402 (GBP)
Organisation European Commission 
Sector Public
Country European Union (EU)
Start 03/2008 
End 08/2012
 
Description Embryonic Stem Cells, Neural stem cells and Neurons
Amount £102,527 (GBP)
Organisation Fidelity Biosciences 
Sector Private
Country United States
Start 05/2007 
End 05/2009
 
Description Japanese Partnership
Amount £56,594 (GBP)
Organisation Biotechnology and Biological Sciences Research Council (BBSRC) 
Sector Public
Country United Kingdom
Start 07/2010 
End 06/2014
 
Description MRC Stem Cell Career Development Fellowship
Amount £279,872 (GBP)
Organisation Medical Research Council (MRC) 
Sector Academic/University
Country United Kingdom
Start 03/2008 
End 07/2011
 
Description NeuroStemcell Project - European consortium for stem Cell therapy
Amount £652,985 (GBP)
Organisation European Commission 
Sector Public
Country European Union (EU)
Start 12/2008 
End 05/2013
 
Description Ole Wiskow Studentship
Amount £22,500 (GBP)
Organisation GlaxoSmithKline (GSK) 
Sector Private
Country Global
Start 01/2007 
End 12/2009
 
Description Plurimes - Pluripotent Stem Cell Resources for Mesodermal Medicine
Amount £1,511,268 (GBP)
Organisation European Commission 
Sector Public
Country European Union (EU)
Start 02/2014 
End 01/2018
 
Description Precision Transgenesis in Rats via Embryonic Stem Cells
Amount £52,827 (GBP)
Organisation National Institutes of Health (NIH) 
Sector Public
Country United States
Start 08/2006 
End 01/2009
 
Description Regulation and function of the pluripotency determinant Nanaog
Amount £844,000 (GBP)
Organisation Wellcome Trust 
Sector Charity/Non Profit
Country United Kingdom
Start 08/2006 
End 10/2010
 
Description Regulation of Self Renewal, Commitment and Differentiation in Brain Cancer Cells
Amount £177,218 (GBP)
Organisation Cancer Research UK 
Sector Charity/Non Profit
Country United Kingdom
Start 06/2008 
End 05/2011
 
Description Steering Embryonic Stem Cells towards Pancreatic
Amount £43,902 (GBP)
Organisation Juvenile Diabetes Research Foundation (JDRF) 
Sector Charity/Non Profit
Country United Kingdom
Start 04/2007 
End 04/2010
 
Description Stem Cell Initiative (Core Grant)
Amount £1,143,873 (GBP)
Organisation Medical Research Council (MRC) 
Sector Academic/University
Country United Kingdom
Start 04/2006 
End 12/2008
 
Description Stemstroke: Towards a Stem Cell Therapy for Stroke
Amount £294,553 (GBP)
Organisation European Commission 
Sector Public
Country European Union (EU)
Start 01/2007 
End 12/2009
 
Description Summer Studentship for Magdelena Stasiulewicz
Amount £2,500 (GBP)
Organisation Biotechnology and Biological Sciences Research Council (BBSRC) 
Sector Public
Country United Kingdom
Start 06/2010 
End 08/2010
 
Description SyBoSS Project - Systems Biology of Stem Cells and Reprogramming
Amount £374,310 (GBP)
Organisation European Commission 
Sector Public
Country European Union (EU)
Start 06/2010 
End 05/2015
 
Description The Discovery of future Neuro-therapeutic Molecules (NEUROscreen)
Amount £195,139 (GBP)
Organisation European Commission 
Sector Public
Country European Union (EU)
Start 08/2007 
End 07/2010
 
Description The Road from Pluripotency to Lineage
Amount £1,736,222 (GBP)
Organisation Wellcome Trust 
Sector Charity/Non Profit
Country United Kingdom
Start 11/2010 
End 10/2015
 
Description The Stat3 pathway in Stem Cell Self renewal and the germline
Amount £1,211,904 (GBP)
Organisation Biotechnology and Biological Sciences Research Council (BBSRC) 
Sector Public
Country United Kingdom
Start 06/2009 
End 05/2013
 
Description Transplantation protocols to assess the ability of ES cell derived endodermal populations to differentiate towards pancreatic lineages
Amount £26,596 (GBP)
Organisation Juvenile Diabetes Research Foundation (JDRF) 
Sector Charity/Non Profit
Country United Kingdom
Start  
 
Title Human NPSC (2014) 
Description Human naïve pluripotent stem cells (2014) 
Type Of Material Cell line 
Year Produced 2014 
Provided To Others? Yes  
Impact Patent filed and licensed. 
 
Title Human naive epiblast-like SC 
Description Human naïve epiblast-like stem cells (2016) 
Type Of Material Cell line 
Year Produced 2016 
Provided To Others? Yes  
Impact Patent filed and licensed. 
 
Description Beta Cell Therapy / SCI 
Organisation JDRF Center for Beta Cell Therapy in Diabetes
Country Belgium 
Sector Academic/University 
PI Contribution Beta Cell Therapy in Diabetes - European Framework 7
Collaborator Contribution Beta Cell Therapy in Diabetes - European Framework 7
Impact n/a
Start Year 2010
 
Description Deep Sequencing 
Organisation Radboud University Nijmegen Medical Center
Country Netherlands 
Sector Academic/University 
PI Contribution Deep Sequencing
Collaborator Contribution Deep Sequencing
Impact n/a
Start Year 2011
 
Description EBI / SCI 
Organisation EMBL European Bioinformatics Institute (EMBL - EBI)
Country United Kingdom 
Sector Academic/University 
PI Contribution Deep sequence analysis
Collaborator Contribution Deep sequence analysis
Impact Publication: Identification of the missing pluripotency mediator downstream of leukaemia inhibitory
Start Year 2011
 
Description EUROSTEMCELL 
Organisation Babraham Institute
Department Stem Cell Sciences UK Ltd
Country United Kingdom 
Sector Charity/Non Profit 
PI Contribution Austin Smith was the coordinator of this collaboration.
Collaborator Contribution xxx
Impact Not given
Start Year 2006
 
Description EUROSTEMCELL 
Organisation Cancer Research UK
Country United Kingdom 
Sector Charity/Non Profit 
PI Contribution Austin Smith was the coordinator of this collaboration.
Collaborator Contribution xxx
Impact Not given
Start Year 2006
 
Description EUROSTEMCELL 
Organisation European Molecular Biology Laboratory
Country Germany 
Sector Public 
PI Contribution Austin Smith was the coordinator of this collaboration.
Collaborator Contribution xxx
Impact Not given
Start Year 2006
 
Description EUROSTEMCELL 
Organisation Imperial College London
Country United Kingdom 
Sector Academic/University 
PI Contribution Austin Smith was the coordinator of this collaboration.
Collaborator Contribution xxx
Impact Not given
Start Year 2006
 
Description EUROSTEMCELL 
Organisation Karolinska Institute
Country Sweden 
Sector Academic/University 
PI Contribution Austin Smith was the coordinator of this collaboration.
Collaborator Contribution xxx
Impact Not given
Start Year 2006
 
Description EUROSTEMCELL 
Organisation Lund University
Country Sweden 
Sector Academic/University 
PI Contribution Austin Smith was the coordinator of this collaboration.
Collaborator Contribution xxx
Impact Not given
Start Year 2006
 
Description EUROSTEMCELL 
Organisation NeuroNova AB
Country Sweden 
Sector Private 
PI Contribution Austin Smith was the coordinator of this collaboration.
Collaborator Contribution xxx
Impact Not given
Start Year 2006
 
Description EUROSTEMCELL 
Organisation NsGene A/S
Country Denmark 
Sector Private 
PI Contribution Austin Smith was the coordinator of this collaboration.
Collaborator Contribution xxx
Impact Not given
Start Year 2006
 
Description EUROSTEMCELL 
Organisation Pasteur Institute, Paris
Country France 
Sector Academic/University 
PI Contribution Austin Smith was the coordinator of this collaboration.
Collaborator Contribution xxx
Impact Not given
Start Year 2006
 
Description EUROSTEMCELL 
Organisation San Raffaele Hospital
Department Stem Cell Research Institute
Country Italy 
Sector Hospitals 
PI Contribution Austin Smith was the coordinator of this collaboration.
Collaborator Contribution xxx
Impact Not given
Start Year 2006
 
Description EUROSTEMCELL 
Organisation Swiss Federal Institute of Technology in Lausanne (EPFL)
Country Switzerland 
Sector Public 
PI Contribution Austin Smith was the coordinator of this collaboration.
Collaborator Contribution xxx
Impact Not given
Start Year 2006
 
Description EUROSTEMCELL 
Organisation The Wellcome Trust Sanger Institute
Country United Kingdom 
Sector Charity/Non Profit 
PI Contribution Austin Smith was the coordinator of this collaboration.
Collaborator Contribution xxx
Impact Not given
Start Year 2006
 
Description EUROSTEMCELL 
Organisation University of Bonn
Department Medical Centre Bonn
Country Germany 
Sector Academic/University 
PI Contribution Austin Smith was the coordinator of this collaboration.
Collaborator Contribution xxx
Impact Not given
Start Year 2006
 
Description EUROSTEMCELL 
Organisation University of Cambridge
Country United Kingdom 
Sector Academic/University 
PI Contribution Austin Smith was the coordinator of this collaboration.
Collaborator Contribution xxx
Impact Not given
Start Year 2006
 
Description EUROSTEMCELL 
Organisation University of Edinburgh
Country United Kingdom 
Sector Academic/University 
PI Contribution Austin Smith was the coordinator of this collaboration.
Collaborator Contribution xxx
Impact Not given
Start Year 2006
 
Description EUROSTEMCELL 
Organisation University of Milan
Country Italy 
Sector Academic/University 
PI Contribution Austin Smith was the coordinator of this collaboration.
Collaborator Contribution xxx
Impact Not given
Start Year 2006
 
Description EuroStemCell 
Organisation Centre for Genomic Regulation (CRG)
Country Spain 
Sector Academic/University 
PI Contribution Austin is a principal investigator for this collaboration
Collaborator Contribution EuroStemCell, launched in March 2010, unites more than 90 European stem cell and regenerative medicine research labs in a coordinated effort to engage with the public about our science. It is a partnership of scientists, clinicians, ethicists, social scientists and science communicators. It is coordinated by the University of Edinburgh
Impact www.eurostemcell.org
Start Year 2010
 
Description EuroStemCell 
Organisation Dando, Weiss & Colucci Ltd
Country United Kingdom 
Sector Private 
PI Contribution Austin is a principal investigator for this collaboration
Collaborator Contribution EuroStemCell, launched in March 2010, unites more than 90 European stem cell and regenerative medicine research labs in a coordinated effort to engage with the public about our science. It is a partnership of scientists, clinicians, ethicists, social scientists and science communicators. It is coordinated by the University of Edinburgh
Impact www.eurostemcell.org
Start Year 2010
 
Description EuroStemCell 
Organisation JDRF Center for Beta Cell Therapy in Diabetes
Country Belgium 
Sector Academic/University 
PI Contribution Austin is a principal investigator for this collaboration
Collaborator Contribution EuroStemCell, launched in March 2010, unites more than 90 European stem cell and regenerative medicine research labs in a coordinated effort to engage with the public about our science. It is a partnership of scientists, clinicians, ethicists, social scientists and science communicators. It is coordinated by the University of Edinburgh
Impact www.eurostemcell.org
Start Year 2010
 
Description EuroStemCell 
Organisation Life and Brain GmbH
Country Germany 
Sector Private 
PI Contribution Austin is a principal investigator for this collaboration
Collaborator Contribution EuroStemCell, launched in March 2010, unites more than 90 European stem cell and regenerative medicine research labs in a coordinated effort to engage with the public about our science. It is a partnership of scientists, clinicians, ethicists, social scientists and science communicators. It is coordinated by the University of Edinburgh
Impact www.eurostemcell.org
Start Year 2010
 
Description EuroStemCell 
Organisation Lund University
Country Sweden 
Sector Academic/University 
PI Contribution Austin is a principal investigator for this collaboration
Collaborator Contribution EuroStemCell, launched in March 2010, unites more than 90 European stem cell and regenerative medicine research labs in a coordinated effort to engage with the public about our science. It is a partnership of scientists, clinicians, ethicists, social scientists and science communicators. It is coordinated by the University of Edinburgh
Impact www.eurostemcell.org
Start Year 2010
 
Description EuroStemCell 
Organisation National Institute of Health and Medical Research (INSERM)
Country France 
Sector Public 
PI Contribution Austin is a principal investigator for this collaboration
Collaborator Contribution EuroStemCell, launched in March 2010, unites more than 90 European stem cell and regenerative medicine research labs in a coordinated effort to engage with the public about our science. It is a partnership of scientists, clinicians, ethicists, social scientists and science communicators. It is coordinated by the University of Edinburgh
Impact www.eurostemcell.org
Start Year 2010
 
Description EuroStemCell 
Organisation National University of Ireland, Galway
Country Ireland 
Sector Academic/University 
PI Contribution Austin is a principal investigator for this collaboration
Collaborator Contribution EuroStemCell, launched in March 2010, unites more than 90 European stem cell and regenerative medicine research labs in a coordinated effort to engage with the public about our science. It is a partnership of scientists, clinicians, ethicists, social scientists and science communicators. It is coordinated by the University of Edinburgh
Impact www.eurostemcell.org
Start Year 2010
 
Description EuroStemCell 
Organisation University of Cambridge
Country United Kingdom 
Sector Academic/University 
PI Contribution Austin is a principal investigator for this collaboration
Collaborator Contribution EuroStemCell, launched in March 2010, unites more than 90 European stem cell and regenerative medicine research labs in a coordinated effort to engage with the public about our science. It is a partnership of scientists, clinicians, ethicists, social scientists and science communicators. It is coordinated by the University of Edinburgh
Impact www.eurostemcell.org
Start Year 2010
 
Description EuroStemCell 
Organisation University of Edinburgh
Country United Kingdom 
Sector Academic/University 
PI Contribution Austin is a principal investigator for this collaboration
Collaborator Contribution EuroStemCell, launched in March 2010, unites more than 90 European stem cell and regenerative medicine research labs in a coordinated effort to engage with the public about our science. It is a partnership of scientists, clinicians, ethicists, social scientists and science communicators. It is coordinated by the University of Edinburgh
Impact www.eurostemcell.org
Start Year 2010
 
Description EuroStemCell 
Organisation University of Milan
Country Italy 
Sector Academic/University 
PI Contribution Austin is a principal investigator for this collaboration
Collaborator Contribution EuroStemCell, launched in March 2010, unites more than 90 European stem cell and regenerative medicine research labs in a coordinated effort to engage with the public about our science. It is a partnership of scientists, clinicians, ethicists, social scientists and science communicators. It is coordinated by the University of Edinburgh
Impact www.eurostemcell.org
Start Year 2010
 
Description EuroStemCell 
Organisation University of Sheffield
Country United Kingdom 
Sector Academic/University 
PI Contribution Austin is a principal investigator for this collaboration
Collaborator Contribution EuroStemCell, launched in March 2010, unites more than 90 European stem cell and regenerative medicine research labs in a coordinated effort to engage with the public about our science. It is a partnership of scientists, clinicians, ethicists, social scientists and science communicators. It is coordinated by the University of Edinburgh
Impact www.eurostemcell.org
Start Year 2010
 
Description FP7 Project Pluripotent Stem Cell resources for mesodermal medicine (PluriMes) 
Organisation European Research Centre for Biology and Medicine (Centre Européen de Recherche en Biologie et en Médecine)
Country France 
Sector Academic/University 
PI Contribution Austin Smith is responsible for overall scientific coordination of the project and leads work package 1, translating current advances and understanding of rodent pluripotency to develop and refine conditions that promote homogeneous naïve state for human pluripotent stem cells.
Collaborator Contribution By interlinking complementary biological and computational expertise, the partners aim to drive the generation of new knowledge on the characteristics of normal and abnormal stem cells. By harnessing the capacity of pluripotent stem cells to produce functional cell types with precision and at scale, researchers hope to enable new treatment modalities for degenerative diseases. The PluriMes project is specifically targeted at therapies for muscle, bone and cartilage.
Impact DOI: http://dx.doi.org/10.1016/j.cell.2014.08.029 DOI:10.1038/nprot.2014.102
Start Year 2014
 
Description FP7 Project Pluripotent Stem Cell resources for mesodermal medicine (PluriMes) 
Organisation Leiden University Medical Center
Country Netherlands 
Sector Multiple 
PI Contribution Austin Smith is responsible for overall scientific coordination of the project and leads work package 1, translating current advances and understanding of rodent pluripotency to develop and refine conditions that promote homogeneous naïve state for human pluripotent stem cells.
Collaborator Contribution By interlinking complementary biological and computational expertise, the partners aim to drive the generation of new knowledge on the characteristics of normal and abnormal stem cells. By harnessing the capacity of pluripotent stem cells to produce functional cell types with precision and at scale, researchers hope to enable new treatment modalities for degenerative diseases. The PluriMes project is specifically targeted at therapies for muscle, bone and cartilage.
Impact DOI: http://dx.doi.org/10.1016/j.cell.2014.08.029 DOI:10.1038/nprot.2014.102
Start Year 2014
 
Description FP7 Project Pluripotent Stem Cell resources for mesodermal medicine (PluriMes) 
Organisation Pluriomics BV
Country Netherlands 
Sector Private 
PI Contribution Austin Smith is responsible for overall scientific coordination of the project and leads work package 1, translating current advances and understanding of rodent pluripotency to develop and refine conditions that promote homogeneous naïve state for human pluripotent stem cells.
Collaborator Contribution By interlinking complementary biological and computational expertise, the partners aim to drive the generation of new knowledge on the characteristics of normal and abnormal stem cells. By harnessing the capacity of pluripotent stem cells to produce functional cell types with precision and at scale, researchers hope to enable new treatment modalities for degenerative diseases. The PluriMes project is specifically targeted at therapies for muscle, bone and cartilage.
Impact DOI: http://dx.doi.org/10.1016/j.cell.2014.08.029 DOI:10.1038/nprot.2014.102
Start Year 2014
 
Description FP7 Project Pluripotent Stem Cell resources for mesodermal medicine (PluriMes) 
Organisation Sapienza University of Rome
Country Italy 
Sector Academic/University 
PI Contribution Austin Smith is responsible for overall scientific coordination of the project and leads work package 1, translating current advances and understanding of rodent pluripotency to develop and refine conditions that promote homogeneous naïve state for human pluripotent stem cells.
Collaborator Contribution By interlinking complementary biological and computational expertise, the partners aim to drive the generation of new knowledge on the characteristics of normal and abnormal stem cells. By harnessing the capacity of pluripotent stem cells to produce functional cell types with precision and at scale, researchers hope to enable new treatment modalities for degenerative diseases. The PluriMes project is specifically targeted at therapies for muscle, bone and cartilage.
Impact DOI: http://dx.doi.org/10.1016/j.cell.2014.08.029 DOI:10.1038/nprot.2014.102
Start Year 2014
 
Description FP7 Project Pluripotent Stem Cell resources for mesodermal medicine (PluriMes) 
Organisation Stem Cell Technologies
Country Canada 
Sector Private 
PI Contribution Austin Smith is responsible for overall scientific coordination of the project and leads work package 1, translating current advances and understanding of rodent pluripotency to develop and refine conditions that promote homogeneous naïve state for human pluripotent stem cells.
Collaborator Contribution By interlinking complementary biological and computational expertise, the partners aim to drive the generation of new knowledge on the characteristics of normal and abnormal stem cells. By harnessing the capacity of pluripotent stem cells to produce functional cell types with precision and at scale, researchers hope to enable new treatment modalities for degenerative diseases. The PluriMes project is specifically targeted at therapies for muscle, bone and cartilage.
Impact DOI: http://dx.doi.org/10.1016/j.cell.2014.08.029 DOI:10.1038/nprot.2014.102
Start Year 2014
 
Description FP7 Project Pluripotent Stem Cell resources for mesodermal medicine (PluriMes) 
Organisation Swiss Federal Institute of Technology in Lausanne (EPFL)
Country Switzerland 
Sector Public 
PI Contribution Austin Smith is responsible for overall scientific coordination of the project and leads work package 1, translating current advances and understanding of rodent pluripotency to develop and refine conditions that promote homogeneous naïve state for human pluripotent stem cells.
Collaborator Contribution By interlinking complementary biological and computational expertise, the partners aim to drive the generation of new knowledge on the characteristics of normal and abnormal stem cells. By harnessing the capacity of pluripotent stem cells to produce functional cell types with precision and at scale, researchers hope to enable new treatment modalities for degenerative diseases. The PluriMes project is specifically targeted at therapies for muscle, bone and cartilage.
Impact DOI: http://dx.doi.org/10.1016/j.cell.2014.08.029 DOI:10.1038/nprot.2014.102
Start Year 2014
 
Description FP7 Project Pluripotent Stem Cell resources for mesodermal medicine (PluriMes) 
Organisation Technical University of Dresden
Country Germany 
Sector Academic/University 
PI Contribution Austin Smith is responsible for overall scientific coordination of the project and leads work package 1, translating current advances and understanding of rodent pluripotency to develop and refine conditions that promote homogeneous naïve state for human pluripotent stem cells.
Collaborator Contribution By interlinking complementary biological and computational expertise, the partners aim to drive the generation of new knowledge on the characteristics of normal and abnormal stem cells. By harnessing the capacity of pluripotent stem cells to produce functional cell types with precision and at scale, researchers hope to enable new treatment modalities for degenerative diseases. The PluriMes project is specifically targeted at therapies for muscle, bone and cartilage.
Impact DOI: http://dx.doi.org/10.1016/j.cell.2014.08.029 DOI:10.1038/nprot.2014.102
Start Year 2014
 
Description FP7 Project Pluripotent Stem Cell resources for mesodermal medicine (PluriMes) 
Organisation University College London
Department Division of Biosciences
Country United Kingdom 
Sector Academic/University 
PI Contribution Austin Smith is responsible for overall scientific coordination of the project and leads work package 1, translating current advances and understanding of rodent pluripotency to develop and refine conditions that promote homogeneous naïve state for human pluripotent stem cells.
Collaborator Contribution By interlinking complementary biological and computational expertise, the partners aim to drive the generation of new knowledge on the characteristics of normal and abnormal stem cells. By harnessing the capacity of pluripotent stem cells to produce functional cell types with precision and at scale, researchers hope to enable new treatment modalities for degenerative diseases. The PluriMes project is specifically targeted at therapies for muscle, bone and cartilage.
Impact DOI: http://dx.doi.org/10.1016/j.cell.2014.08.029 DOI:10.1038/nprot.2014.102
Start Year 2014
 
Description FP7 Project Pluripotent Stem Cell resources for mesodermal medicine (PluriMes) 
Organisation University of Sheffield
Country United Kingdom 
Sector Academic/University 
PI Contribution Austin Smith is responsible for overall scientific coordination of the project and leads work package 1, translating current advances and understanding of rodent pluripotency to develop and refine conditions that promote homogeneous naïve state for human pluripotent stem cells.
Collaborator Contribution By interlinking complementary biological and computational expertise, the partners aim to drive the generation of new knowledge on the characteristics of normal and abnormal stem cells. By harnessing the capacity of pluripotent stem cells to produce functional cell types with precision and at scale, researchers hope to enable new treatment modalities for degenerative diseases. The PluriMes project is specifically targeted at therapies for muscle, bone and cartilage.
Impact DOI: http://dx.doi.org/10.1016/j.cell.2014.08.029 DOI:10.1038/nprot.2014.102
Start Year 2014
 
Description Gene Targeting/ Univ of Edinburgh/ SCI 
Organisation University of Edinburgh
Department The Roslin Institute
Country United Kingdom 
Sector Academic/University 
PI Contribution Gene targeting by homologous recombination in the rat
Collaborator Contribution Gene targeting by homologous recombination in the rat
Impact n./a
Start Year 2010
 
Description JPA/ CSCR 
Organisation RIKEN
Department RIKEN Center for Developmental Biology
Country Japan 
Sector Public 
PI Contribution Metanalysis of transcriptional circuitries and simulation of robustness, flexibility and dynamic heterogeneity
Collaborator Contribution Metanalysis of transcriptional circuitries and simulation of robustness, flexibility and dynamic heterogeneity
Impact n/a
Start Year 2010
 
Description Methylation analyses 
Organisation Babraham Institute
Country United Kingdom 
Sector Private 
PI Contribution Methylation analyses
Collaborator Contribution Methylation analyses
Impact n/a
Start Year 2011
 
Description NeuroStemCell 
Organisation Babraham Institute
Department Stem Cell Sciences UK Ltd
Country United Kingdom 
Sector Charity/Non Profit 
PI Contribution Austin Smith is a Principal Investigator on this collaboration. Austin will contribute extensively to WP1 and 2 and play a role in stability studies in WP5. The group will provide to the consortium recently derived rat ES cells and rat NS cells, in addition to human NS cells.
Collaborator Contribution European Consortium for Stem Cell Therapy in Neurodegenerative Diseases. NeuroStemcell, which comprises 13 academic partners and 2 SMEs and 1 Research Enterprise from 6 European countries and the United States of America, is formed to create a world-leading consortium that can develop stem cell based therapies for Parkinson´s disease and Huntington´s disease toward clinical application. NeuroStemcell is focused on the identification and systematic comparison of progenitor cell lines with the most favourable characteristics for mesencephalic dopaminergic and striatal GABAergic neuronal differentiation, generated either directly from human embryonic stem (ES) cells, from induced Pluripotent Stem (iPS) cells, or from neural stem cells derived from either ES cells, iPS cells or fetal brain, and perform rigorous and systematic testing of the most prominent candidate cells in appropriate animal models.
Impact http://www.neurostemcell.org/
Start Year 2008
 
Description NeuroStemCell 
Organisation Cardiff University
Department School of Biosciences
Country United Kingdom 
Sector Academic/University 
PI Contribution Austin Smith is a Principal Investigator on this collaboration. Austin will contribute extensively to WP1 and 2 and play a role in stability studies in WP5. The group will provide to the consortium recently derived rat ES cells and rat NS cells, in addition to human NS cells.
Collaborator Contribution European Consortium for Stem Cell Therapy in Neurodegenerative Diseases. NeuroStemcell, which comprises 13 academic partners and 2 SMEs and 1 Research Enterprise from 6 European countries and the United States of America, is formed to create a world-leading consortium that can develop stem cell based therapies for Parkinson´s disease and Huntington´s disease toward clinical application. NeuroStemcell is focused on the identification and systematic comparison of progenitor cell lines with the most favourable characteristics for mesencephalic dopaminergic and striatal GABAergic neuronal differentiation, generated either directly from human embryonic stem (ES) cells, from induced Pluripotent Stem (iPS) cells, or from neural stem cells derived from either ES cells, iPS cells or fetal brain, and perform rigorous and systematic testing of the most prominent candidate cells in appropriate animal models.
Impact http://www.neurostemcell.org/
Start Year 2008
 
Description NeuroStemCell 
Organisation Imperial College London
Country United Kingdom 
Sector Academic/University 
PI Contribution Austin Smith is a Principal Investigator on this collaboration. Austin will contribute extensively to WP1 and 2 and play a role in stability studies in WP5. The group will provide to the consortium recently derived rat ES cells and rat NS cells, in addition to human NS cells.
Collaborator Contribution European Consortium for Stem Cell Therapy in Neurodegenerative Diseases. NeuroStemcell, which comprises 13 academic partners and 2 SMEs and 1 Research Enterprise from 6 European countries and the United States of America, is formed to create a world-leading consortium that can develop stem cell based therapies for Parkinson´s disease and Huntington´s disease toward clinical application. NeuroStemcell is focused on the identification and systematic comparison of progenitor cell lines with the most favourable characteristics for mesencephalic dopaminergic and striatal GABAergic neuronal differentiation, generated either directly from human embryonic stem (ES) cells, from induced Pluripotent Stem (iPS) cells, or from neural stem cells derived from either ES cells, iPS cells or fetal brain, and perform rigorous and systematic testing of the most prominent candidate cells in appropriate animal models.
Impact http://www.neurostemcell.org/
Start Year 2008
 
Description NeuroStemCell 
Organisation Institute of Biomedical Imagery (I2BM)
Country France 
Sector Academic/University 
PI Contribution Austin Smith is a Principal Investigator on this collaboration. Austin will contribute extensively to WP1 and 2 and play a role in stability studies in WP5. The group will provide to the consortium recently derived rat ES cells and rat NS cells, in addition to human NS cells.
Collaborator Contribution European Consortium for Stem Cell Therapy in Neurodegenerative Diseases. NeuroStemcell, which comprises 13 academic partners and 2 SMEs and 1 Research Enterprise from 6 European countries and the United States of America, is formed to create a world-leading consortium that can develop stem cell based therapies for Parkinson´s disease and Huntington´s disease toward clinical application. NeuroStemcell is focused on the identification and systematic comparison of progenitor cell lines with the most favourable characteristics for mesencephalic dopaminergic and striatal GABAergic neuronal differentiation, generated either directly from human embryonic stem (ES) cells, from induced Pluripotent Stem (iPS) cells, or from neural stem cells derived from either ES cells, iPS cells or fetal brain, and perform rigorous and systematic testing of the most prominent candidate cells in appropriate animal models.
Impact http://www.neurostemcell.org/
Start Year 2008
 
Description NeuroStemCell 
Organisation Karolinska Institute
Country Sweden 
Sector Academic/University 
PI Contribution Austin Smith is a Principal Investigator on this collaboration. Austin will contribute extensively to WP1 and 2 and play a role in stability studies in WP5. The group will provide to the consortium recently derived rat ES cells and rat NS cells, in addition to human NS cells.
Collaborator Contribution European Consortium for Stem Cell Therapy in Neurodegenerative Diseases. NeuroStemcell, which comprises 13 academic partners and 2 SMEs and 1 Research Enterprise from 6 European countries and the United States of America, is formed to create a world-leading consortium that can develop stem cell based therapies for Parkinson´s disease and Huntington´s disease toward clinical application. NeuroStemcell is focused on the identification and systematic comparison of progenitor cell lines with the most favourable characteristics for mesencephalic dopaminergic and striatal GABAergic neuronal differentiation, generated either directly from human embryonic stem (ES) cells, from induced Pluripotent Stem (iPS) cells, or from neural stem cells derived from either ES cells, iPS cells or fetal brain, and perform rigorous and systematic testing of the most prominent candidate cells in appropriate animal models.
Impact http://www.neurostemcell.org/
Start Year 2008
 
Description NeuroStemCell 
Organisation Lund University
Country Sweden 
Sector Academic/University 
PI Contribution Austin Smith is a Principal Investigator on this collaboration. Austin will contribute extensively to WP1 and 2 and play a role in stability studies in WP5. The group will provide to the consortium recently derived rat ES cells and rat NS cells, in addition to human NS cells.
Collaborator Contribution European Consortium for Stem Cell Therapy in Neurodegenerative Diseases. NeuroStemcell, which comprises 13 academic partners and 2 SMEs and 1 Research Enterprise from 6 European countries and the United States of America, is formed to create a world-leading consortium that can develop stem cell based therapies for Parkinson´s disease and Huntington´s disease toward clinical application. NeuroStemcell is focused on the identification and systematic comparison of progenitor cell lines with the most favourable characteristics for mesencephalic dopaminergic and striatal GABAergic neuronal differentiation, generated either directly from human embryonic stem (ES) cells, from induced Pluripotent Stem (iPS) cells, or from neural stem cells derived from either ES cells, iPS cells or fetal brain, and perform rigorous and systematic testing of the most prominent candidate cells in appropriate animal models.
Impact http://www.neurostemcell.org/
Start Year 2008
 
Description NeuroStemCell 
Organisation National Institute of Health and Medical Research (INSERM)
Country France 
Sector Public 
PI Contribution Austin Smith is a Principal Investigator on this collaboration. Austin will contribute extensively to WP1 and 2 and play a role in stability studies in WP5. The group will provide to the consortium recently derived rat ES cells and rat NS cells, in addition to human NS cells.
Collaborator Contribution European Consortium for Stem Cell Therapy in Neurodegenerative Diseases. NeuroStemcell, which comprises 13 academic partners and 2 SMEs and 1 Research Enterprise from 6 European countries and the United States of America, is formed to create a world-leading consortium that can develop stem cell based therapies for Parkinson´s disease and Huntington´s disease toward clinical application. NeuroStemcell is focused on the identification and systematic comparison of progenitor cell lines with the most favourable characteristics for mesencephalic dopaminergic and striatal GABAergic neuronal differentiation, generated either directly from human embryonic stem (ES) cells, from induced Pluripotent Stem (iPS) cells, or from neural stem cells derived from either ES cells, iPS cells or fetal brain, and perform rigorous and systematic testing of the most prominent candidate cells in appropriate animal models.
Impact http://www.neurostemcell.org/
Start Year 2008
 
Description NeuroStemCell 
Organisation NsGene A/S
Country Denmark 
Sector Private 
PI Contribution Austin Smith is a Principal Investigator on this collaboration. Austin will contribute extensively to WP1 and 2 and play a role in stability studies in WP5. The group will provide to the consortium recently derived rat ES cells and rat NS cells, in addition to human NS cells.
Collaborator Contribution European Consortium for Stem Cell Therapy in Neurodegenerative Diseases. NeuroStemcell, which comprises 13 academic partners and 2 SMEs and 1 Research Enterprise from 6 European countries and the United States of America, is formed to create a world-leading consortium that can develop stem cell based therapies for Parkinson´s disease and Huntington´s disease toward clinical application. NeuroStemcell is focused on the identification and systematic comparison of progenitor cell lines with the most favourable characteristics for mesencephalic dopaminergic and striatal GABAergic neuronal differentiation, generated either directly from human embryonic stem (ES) cells, from induced Pluripotent Stem (iPS) cells, or from neural stem cells derived from either ES cells, iPS cells or fetal brain, and perform rigorous and systematic testing of the most prominent candidate cells in appropriate animal models.
Impact http://www.neurostemcell.org/
Start Year 2008
 
Description NeuroStemCell 
Organisation Sapio
Department BioRep
Country Italy 
Sector Private 
PI Contribution Austin Smith is a Principal Investigator on this collaboration. Austin will contribute extensively to WP1 and 2 and play a role in stability studies in WP5. The group will provide to the consortium recently derived rat ES cells and rat NS cells, in addition to human NS cells.
Collaborator Contribution European Consortium for Stem Cell Therapy in Neurodegenerative Diseases. NeuroStemcell, which comprises 13 academic partners and 2 SMEs and 1 Research Enterprise from 6 European countries and the United States of America, is formed to create a world-leading consortium that can develop stem cell based therapies for Parkinson´s disease and Huntington´s disease toward clinical application. NeuroStemcell is focused on the identification and systematic comparison of progenitor cell lines with the most favourable characteristics for mesencephalic dopaminergic and striatal GABAergic neuronal differentiation, generated either directly from human embryonic stem (ES) cells, from induced Pluripotent Stem (iPS) cells, or from neural stem cells derived from either ES cells, iPS cells or fetal brain, and perform rigorous and systematic testing of the most prominent candidate cells in appropriate animal models.
Impact http://www.neurostemcell.org/
Start Year 2008
 
Description NeuroStemCell 
Organisation University of Bonn
Country Germany 
Sector Academic/University 
PI Contribution Austin Smith is a Principal Investigator on this collaboration. Austin will contribute extensively to WP1 and 2 and play a role in stability studies in WP5. The group will provide to the consortium recently derived rat ES cells and rat NS cells, in addition to human NS cells.
Collaborator Contribution European Consortium for Stem Cell Therapy in Neurodegenerative Diseases. NeuroStemcell, which comprises 13 academic partners and 2 SMEs and 1 Research Enterprise from 6 European countries and the United States of America, is formed to create a world-leading consortium that can develop stem cell based therapies for Parkinson´s disease and Huntington´s disease toward clinical application. NeuroStemcell is focused on the identification and systematic comparison of progenitor cell lines with the most favourable characteristics for mesencephalic dopaminergic and striatal GABAergic neuronal differentiation, generated either directly from human embryonic stem (ES) cells, from induced Pluripotent Stem (iPS) cells, or from neural stem cells derived from either ES cells, iPS cells or fetal brain, and perform rigorous and systematic testing of the most prominent candidate cells in appropriate animal models.
Impact http://www.neurostemcell.org/
Start Year 2008
 
Description NeuroStemCell 
Organisation University of Cambridge
Country United Kingdom 
Sector Academic/University 
PI Contribution Austin Smith is a Principal Investigator on this collaboration. Austin will contribute extensively to WP1 and 2 and play a role in stability studies in WP5. The group will provide to the consortium recently derived rat ES cells and rat NS cells, in addition to human NS cells.
Collaborator Contribution European Consortium for Stem Cell Therapy in Neurodegenerative Diseases. NeuroStemcell, which comprises 13 academic partners and 2 SMEs and 1 Research Enterprise from 6 European countries and the United States of America, is formed to create a world-leading consortium that can develop stem cell based therapies for Parkinson´s disease and Huntington´s disease toward clinical application. NeuroStemcell is focused on the identification and systematic comparison of progenitor cell lines with the most favourable characteristics for mesencephalic dopaminergic and striatal GABAergic neuronal differentiation, generated either directly from human embryonic stem (ES) cells, from induced Pluripotent Stem (iPS) cells, or from neural stem cells derived from either ES cells, iPS cells or fetal brain, and perform rigorous and systematic testing of the most prominent candidate cells in appropriate animal models.
Impact http://www.neurostemcell.org/
Start Year 2008
 
Description NeuroStemCell 
Organisation University of Milan
Country Italy 
Sector Academic/University 
PI Contribution Austin Smith is a Principal Investigator on this collaboration. Austin will contribute extensively to WP1 and 2 and play a role in stability studies in WP5. The group will provide to the consortium recently derived rat ES cells and rat NS cells, in addition to human NS cells.
Collaborator Contribution European Consortium for Stem Cell Therapy in Neurodegenerative Diseases. NeuroStemcell, which comprises 13 academic partners and 2 SMEs and 1 Research Enterprise from 6 European countries and the United States of America, is formed to create a world-leading consortium that can develop stem cell based therapies for Parkinson´s disease and Huntington´s disease toward clinical application. NeuroStemcell is focused on the identification and systematic comparison of progenitor cell lines with the most favourable characteristics for mesencephalic dopaminergic and striatal GABAergic neuronal differentiation, generated either directly from human embryonic stem (ES) cells, from induced Pluripotent Stem (iPS) cells, or from neural stem cells derived from either ES cells, iPS cells or fetal brain, and perform rigorous and systematic testing of the most prominent candidate cells in appropriate animal models.
Impact http://www.neurostemcell.org/
Start Year 2008
 
Title Resetting pluripotent stem cells 
Description n.a 
IP Reference  
Protection Patent application published
Year Protection Granted 2014
Licensed No
Impact n.a
 
Description 25 Years of Embryonic Stem Cells in Cambridge 
Form Of Engagement Activity A formal working group, expert panel or dialogue
Part Of Official Scheme? Yes
Geographic Reach National
Primary Audience Other academic audiences (collaborators, peers etc.)
Results and Impact Discussion post event
Year(s) Of Engagement Activity 2006
 
Description A Stem Cell Story, Edinburgh 
Form Of Engagement Activity A magazine, newsletter or online publication
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Public/other audiences
Results and Impact Editorial advisor and contributor to the animated film, "A Stem Cell Story"

Best TV/video production, Tromsø Science Media Festival
Best short film, Scinema (Australia)
In competition, Science Film Festival (Bangkok), BaKaFORUM 2007, Vedere la Scienza
Year(s) Of Engagement Activity 2006
 
Description A Stem Cell Story, Edinburgh 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Public/other audiences
Results and Impact Work on animated film "A Stem Cell Story" for EuroStemCell.

N/A
Year(s) Of Engagement Activity 2006
 
Description A Student's Guide to DNA and Genetics, London 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach Regional
Primary Audience Schools
Results and Impact Talk to 900 A-level students, The Training Partnership, Institute of Education, speaker

N/A
Year(s) Of Engagement Activity 2009
 
Description AbCam - Rediscovering Pluripotency 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? Yes
Geographic Reach International
Primary Audience Health professionals
Results and Impact The talk encouraged thinking and discussions

n.a
Year(s) Of Engagement Activity 2011
URL http://www.abcam.com/index.html?pageconfig=resource&rid=13408
 
Description Alumni Weekend, Cambridge 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach Local
Primary Audience Public/other audiences
Results and Impact Alumni Weekend, Newnham College, Cambridge, Speaker

N/A
Year(s) Of Engagement Activity 2010
 
Description An Interview with Austin Smith 
Form Of Engagement Activity A press release, press conference or response to a media enquiry/interview
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Public/other audiences
Results and Impact An interview piece by Caterina Vicente, originally publised in Development; republised by, The Node & EuroStemCell and widely shared on Twitter.
Outcome:
This activity contributes to our strategic objective to engage hard to reach adults
Year(s) Of Engagement Activity 2015
 
Description Authored materials for EuroStemCell 
Form Of Engagement Activity A magazine, newsletter or online publication
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Public/other audiences
Results and Impact Professor Austin Smith authored materials for EuroStemCell. These were used on their website which is a source of information about Stem Cells. This website is promoted to the general public.
Year(s) Of Engagement Activity 2014
 
Description Cambridge Science Festival 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Type Of Presentation Keynote/Invited Speaker
Geographic Reach Local
Primary Audience Public/other audiences
Results and Impact 120 public attended the presentation and slide show. There was a Q&A at the end of the talk.

n/a
Year(s) Of Engagement Activity 2013
 
Description Cambridge Science Festival 2015 
Form Of Engagement Activity Participation in an open day or visit at my research institution
Part Of Official Scheme? No
Geographic Reach Regional
Primary Audience Public/other audiences
Results and Impact Ge Guo and Sam Myers from the Smith Lab took part in the Cambridge Science Festival 2015 - the theme was Differentiate Me.
'Differentiate Me' was a hands on exhibit at the Cambridge Guildhall designed by SCI researchers. It involved 3 activity stations, suitable for a wide age-range, all of which aimed to teach the fundamental principle of differentiation:
Cell transformers - a mock wet lab activity where children dress in lab-coats and goggles
The Blood Station - modelling different types of cell in play-doh
Race to Differentiate - a multi-player custom designed board game
Outcome:
We had positive face-to-face reactions with hundreds of children and their families, which helps to meet our strategic objective to engage Cambridge families.
Year(s) Of Engagement Activity 2015
 
Description Cambridge ideas that could change the world, Cambridge 
Form Of Engagement Activity Participation in an activity, workshop or similar
Part Of Official Scheme? No
Geographic Reach Regional
Primary Audience Public/other audiences
Results and Impact Cambridge Network Open Meeting

N/A
Year(s) Of Engagement Activity 2009
 
Description Cardiff Scientific Society 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Type Of Presentation Keynote/Invited Speaker
Geographic Reach National
Primary Audience Public/other audiences
Results and Impact Presented the Sir Martin Evans Lecure to Cardiff Scientfic Society members.

n/a
Year(s) Of Engagement Activity 2012
 
Description Cell Therapy, Filmed Interview 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach Regional
Primary Audience Public/other audiences
Results and Impact JDRF Centre for Beta Cell Therapy in Diabetes, interviewee

N/A
Year(s) Of Engagement Activity 2009
 
Description Cellbound development - Development of the scientific content for a computer game to be used at live events 
Form Of Engagement Activity Engagement focused website, blog or social media channel
Part Of Official Scheme? No
Geographic Reach Local
Primary Audience Other audiences
Results and Impact At this pilot event, 20 games developers were offered a crash course in stem cell biology, including a hands-on tour of the laboratories. They then had 48 hours to create a new computer game on the theme 'Destiny & Decisions' in stem cell research.
Year(s) Of Engagement Activity 2016
 
Description Comparing iPS cells and hES cells, Lund, Sweden 
Form Of Engagement Activity Participation in an activity, workshop or similar
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Policymakers/politicians
Results and Impact ESTOOL: Ethical Aspects of Research on Interspecies Embryos and IPS Cells, Panel participant

N/A
Year(s) Of Engagement Activity 2008
 
Description Debating Matters, Cambridge 
Form Of Engagement Activity Participation in an activity, workshop or similar
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Schools
Results and Impact Institute of Ideas and Pfizer Debating Matters Competition, Judge

N/A
Year(s) Of Engagement Activity 2009
 
Description Dinner at the British Embassy, Switzerland 
Form Of Engagement Activity A formal working group, expert panel or dialogue
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Policymakers/politicians
Results and Impact n.a
Year(s) Of Engagement Activity 2010
 
Description Discovery - The Stem Cell Story, BBC World Service 
Form Of Engagement Activity A magazine, newsletter or online publication
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Media (as a channel to the public)
Results and Impact Interview with Sue Broom, presenter of "Discovery - The Stem Cell Story" on BBC World Service

N/A
Year(s) Of Engagement Activity 2009
 
Description Documentary, Edinburgh College of Art 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Public/other audiences
Results and Impact Filming 'The Definitive Story of Stem Cells' (working title)

N/A
Year(s) Of Engagement Activity 2008
 
Description Filmed interview - cell therapy 
Form Of Engagement Activity A press release, press conference or response to a media enquiry/interview
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Public/other audiences
Results and Impact Interview encouraged discussions

n.a
Year(s) Of Engagement Activity 2009
 
Description Game Jam - Smith Lab 
Form Of Engagement Activity Participation in an activity, workshop or similar
Part Of Official Scheme? No
Geographic Reach Local
Primary Audience Public/other audiences
Results and Impact At this pilot event, 20 games developers were offered a crash course in stem cell biology, including a hands-on tour of the laboratories. They then had 48 hours to create a new computer game on the theme 'Destiny & Decisions' in stem cell research. Members of the Smith lab took the game developers on a tour of the lab and provided them with the crash course of stem cells. The smith lab members were also available on the day to answer questions or help provide scientific content.
Outcome:
This activity contributes to our strategic objective to engage hard to reach adults
Year(s) Of Engagement Activity 2015
 
Description Growing Businesses with Stem Cells, Cambridge 
Form Of Engagement Activity Participation in an activity, workshop or similar
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Policymakers/politicians
Results and Impact CULIL/EESCN

N/A
Year(s) Of Engagement Activity 2009
 
Description Hosted Nuffield student placement 
Form Of Engagement Activity Participation in an open day or visit at my research institution
Part Of Official Scheme? No
Geographic Reach Local
Primary Audience Schools
Results and Impact 3 A Level students undertook 4 week research placements to experience working in a laboratory environment. Including talks, tours & visits to several labs. The Smith lab hosted a Nuffield student for 4 weeks. The students were with the lab for 4 weeks and shadowed the scientists in the labs, They also arranged times for the students to read journals and attend seminars. At the end of the 4 weeks, the students had to produce a poster on the work they had conducted over the four weeks. Austin was the overall supervisor for his student, however 4 of his lab members were daily supervisors of the student.

The student in the Smith Lab reported a high level of learning and personal development as well as an increased interest in studying biology. This activity contributes to our strategic objective to engage under-served schools and young people
Year(s) Of Engagement Activity 2015
 
Description Ideas to Reality, Cambridge 
Form Of Engagement Activity Participation in an activity, workshop or similar
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Public/other audiences
Results and Impact Cambridge Enterprise

N/A
Year(s) Of Engagement Activity 2009
 
Description International Summer School, Cambridge 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Schools
Results and Impact University of Cambridge International Summer School, Guest Lecturer

N/A
Year(s) Of Engagement Activity 2006
 
Description International Summer School, Cambridge 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Schools
Results and Impact University of Cambridge International Summer School, Guest Lecturer

N/A
Year(s) Of Engagement Activity 2008
 
Description International Summer School, Cambridge 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Schools
Results and Impact University of Cambridge International Summer School, Guest Lecturer

N/A
Year(s) Of Engagement Activity 2009
 
Description International Summer School, Cambridge 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Schools
Results and Impact University of Cambridge International Summer School, Guest Lecturer

N/A
Year(s) Of Engagement Activity 2007
 
Description Interview for AAAS - Science Magazine, Berlin 
Form Of Engagement Activity A press release, press conference or response to a media enquiry/interview
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Media (as a channel to the public)
Results and Impact n/a
Year(s) Of Engagement Activity 2012
 
Description Interview for Agence France Presse 
Form Of Engagement Activity A press release, press conference or response to a media enquiry/interview
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Media (as a channel to the public)
Results and Impact n/a
Year(s) Of Engagement Activity 2012
 
Description Interview for the University of Cambridge Radio 
Form Of Engagement Activity A press release, press conference or response to a media enquiry/interview
Part Of Official Scheme? No
Geographic Reach Local
Primary Audience Other academic audiences (collaborators, peers etc.)
Results and Impact Interview for the University of Cambridge Radio Station

Promoted the work of the Stem Cell Institute
Year(s) Of Engagement Activity 2014
 
Description Interview with Alice Park, Time Magazine 
Form Of Engagement Activity A press release, press conference or response to a media enquiry/interview
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Public/other audiences
Results and Impact increased awareness of Stems Cells in the media

n.a
Year(s) Of Engagement Activity 2014
 
Description Interview with Anna Azvolinsky, Science 
Form Of Engagement Activity A magazine, newsletter or online publication
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Other academic audiences (collaborators, peers etc.)
Results and Impact Spread information about the Stem Cell Institute

n.a
Year(s) Of Engagement Activity 2014
 
Description Interview with BBC Radio Cambridge 
Form Of Engagement Activity A press release, press conference or response to a media enquiry/interview
Part Of Official Scheme? No
Geographic Reach Local
Primary Audience Media (as a channel to the public)
Results and Impact Sparked interest in Stem Cell Biology

n.a
Year(s) Of Engagement Activity 2014
 
Description Interview with Fabian Ketschmer, Der Standard 
Form Of Engagement Activity A magazine, newsletter or online publication
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Other academic audiences (collaborators, peers etc.)
Results and Impact Increased awareness of the UK Stem Cell Science developments

n.a
Year(s) Of Engagement Activity 2013
 
Description Interview with Heart Radio 
Form Of Engagement Activity A press release, press conference or response to a media enquiry/interview
Part Of Official Scheme? No
Geographic Reach Regional
Primary Audience Public/other audiences
Results and Impact Interview with the local radio station to discuss Stem Cells and the work being done in this field

Increased awareness of the work being done in Cambridge in the Stem Cell field.
Year(s) Of Engagement Activity 2012
 
Description Interview with Rob Stein, NPR 
Form Of Engagement Activity A press release, press conference or response to a media enquiry/interview
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Media (as a channel to the public)
Results and Impact Increased awareness around Stem Cell Biology

not known
Year(s) Of Engagement Activity 2014
 
Description Interview with The Asahi Shimbun 
Form Of Engagement Activity A magazine, newsletter or online publication
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Other academic audiences (collaborators, peers etc.)
Results and Impact The Asahi Shimbun is one of the five national newspapers in Japan - after the interview this promoted the relationship between Stem Cell Science in the UK and Japan

Increased awareness of UK Stem Cell Science in Japan
Year(s) Of Engagement Activity 2013
 
Description Interview, BBC Radio, Cambridge 
Form Of Engagement Activity A press release, press conference or response to a media enquiry/interview
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Media (as a channel to the public)
Results and Impact Interview on peer review with Palab Ghosh, BBC Radio

N/A
Year(s) Of Engagement Activity 2010
 
Description Interview, Milwaukee Journal Sentinel 
Form Of Engagement Activity A magazine, newsletter or online publication
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Media (as a channel to the public)
Results and Impact Interview with Mark Johnson, Milwaukee Journal Sentinel

N/A
Year(s) Of Engagement Activity 2008
 
Description Interview, New Scientist etc 
Form Of Engagement Activity A magazine, newsletter or online publication
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Media (as a channel to the public)
Results and Impact Follow up interview to the above, New Scientist and other media

N/A
Year(s) Of Engagement Activity 2010
 
Description Interview, The Guardian 
Form Of Engagement Activity A press release, press conference or response to a media enquiry/interview
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Media (as a channel to the public)
Results and Impact Interview with Sarah Boseley, Health Editor, The Guardian

N/A
Year(s) Of Engagement Activity 2008
 
Description Interview, The Sun 
Form Of Engagement Activity A press release, press conference or response to a media enquiry/interview
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Public/other audiences
Results and Impact Interview with Jane Symons, Health Correspondent, The Sun

N/A
Year(s) Of Engagement Activity 2008
 
Description Judge at the game jam 
Form Of Engagement Activity Participation in an activity, workshop or similar
Part Of Official Scheme? No
Geographic Reach Local
Primary Audience Public/other audiences
Results and Impact At this pilot event, 20 games developers were offered a crash course in stem cell biology, including a hands-on tour of the laboratories. They then had 48 hours to create a new computer game on the theme 'Destiny & Decisions' in stem cell research. Austin Smith was on the judging panel.
Outcome:
This activity contributes to our strategic objective to engage hard to reach adults
Year(s) Of Engagement Activity 2015
 
Description Lecture at Croucher Foundation Advanced Study Institute 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Postgraduate students
Results and Impact Lecture prompted discussions and questions

Have been invited back in Jan 2014 to present again
Year(s) Of Engagement Activity 2013
 
Description Lecture, Cambridge 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Health professionals
Results and Impact Cambridge Society for Applied Research, lecturer

N/A
Year(s) Of Engagement Activity 2010
 
Description Lecture, Edinburgh 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Public/other audiences
Results and Impact Lecture for the Office of Lifelong Learning, University of Edinburgh

N/A
Year(s) Of Engagement Activity 2009
 
Description Literary Festival 2014 
Form Of Engagement Activity Participation in an open day or visit at my research institution
Part Of Official Scheme? No
Geographic Reach Regional
Primary Audience Public/other audiences
Results and Impact The talk resulted in increased interest in the work of the Stem Cell Institute

Asked for participation in the next event
Year(s) Of Engagement Activity 2014
 
Description MRC/MRCT promotion, Tokyo 
Form Of Engagement Activity Participation in an activity, workshop or similar
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Policymakers/politicians
Results and Impact Raise the Profile of MRC Funded Science in Japan, British Embassy

N/A
Year(s) Of Engagement Activity 2009
 
Description Media Round Table, Amsterdam 
Form Of Engagement Activity A press release, press conference or response to a media enquiry/interview
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Media (as a channel to the public)
Results and Impact "Stem cells: the next 20 years; natural versus induced pluripotency", EMBO, Amsterdam

N/A
Year(s) Of Engagement Activity 2009
 
Description Meeting with Dr Evan Harris, Liberal Democrat Shadow Science and Innovation Minister 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Policymakers/politicians
Results and Impact NA
Year(s) Of Engagement Activity 2009
 
Description Network Meeting, Melbourne, Australia 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Health professionals
Results and Impact TeamVIC Network Meeting

N/A
Year(s) Of Engagement Activity 2009
 
Description Nuffield Research Placement 
Form Of Engagement Activity Participation in an open day or visit at my research institution
Part Of Official Scheme? No
Geographic Reach Local
Primary Audience Schools
Results and Impact Sixth-form student completed a 4-week placement in the Smith Lab.
Year(s) Of Engagement Activity 2016
 
Description Open Meeting, Edinburgh 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Health professionals
Results and Impact Open meeting on Public Engagement on Stem Cell Research, panel member

N/A
Year(s) Of Engagement Activity 2008
 
Description Oxbridge Academic Programmes - Tour 
Form Of Engagement Activity Participation in an open day or visit at my research institution
Part Of Official Scheme? No
Geographic Reach Local
Primary Audience Schools
Results and Impact 15 sixth form students were invited for a lab tour of the lab. Stanley Strawbridge (Smith Lab) showed the student around the lab and talked them through the work which is conducted in the smith lab.
Year(s) Of Engagement Activity 2015
 
Description Parliamentary Office of Science and Techonolgy, London 
Form Of Engagement Activity A formal working group, expert panel or dialogue
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Policymakers/politicians
Results and Impact Considering the scientific developments in stem cell research in last ten years, specifically:
1. ESC lineage restriction and induction of differentiation to produce specific cell types (lineage programming)
2. Scientific developments in cell transplantation, specially ESC-derived neuronal cells to treat neurodegenerative diseases
3. The potential of ESCs in cell replacement therapies
4. potential/limitations of iPSC research concerning therapeutic applications
5. Whether iPSC are equivalent to ESCs
6. Fundamental research on ESC is it necessary
7. Future outcomes for stem cell research

Meeting was with Parliamentary Adviser Dr Mara Almeida
Year(s) Of Engagement Activity 2011
 
Description Photoshoot - 'The Philanthropist' magazine 
Form Of Engagement Activity A magazine, newsletter or online publication
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Public/other audiences
Results and Impact An interview and photo-shoot for Cambridge University's 'The Philanthropist' magazine - a feature about the work of the Cambridge Stem Cell Institute

Increased awareness of the work of the Cambridge Stem Cell Institute
Year(s) Of Engagement Activity 2012
 
Description Pint of Science 2015 
Form Of Engagement Activity Participation in an activity, workshop or similar
Part Of Official Scheme? No
Geographic Reach Local
Primary Audience Public/other audiences
Results and Impact Pint of Science hosts scientific talks and events in various pubs around the world. There were several venues in Cambridge, but the main stem cell talks were at the Panton Arms. Stanley Strawbridge (PhD student in the smith lab) was on the committee and helped organise the talks across Cambridge. He was also responsible for promoting the event to the general public.
Year(s) Of Engagement Activity 2015
 
Description Plenary Talk, Cambridge 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Health professionals
Results and Impact Caius Medical Association (approx 60-80 Caius medical alumni), plenary speaker

N/A
Year(s) Of Engagement Activity 2010
 
Description Post-doc careers workshop, Warwick 
Form Of Engagement Activity Participation in an activity, workshop or similar
Part Of Official Scheme? No
Geographic Reach Regional
Primary Audience Health professionals
Results and Impact Post-doc careers Workshop @ University of Warwick, British Society of Cell Biology, Session Chair

N/A
Year(s) Of Engagement Activity 2010
 
Description Press Round Table, Dresden 
Form Of Engagement Activity A press release, press conference or response to a media enquiry/interview
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Media (as a channel to the public)
Results and Impact Press Round Table, 2nd International Congress on Stem Cells

N/A
Year(s) Of Engagement Activity 2008
 
Description Public Culture as Professional Science, London 
Form Of Engagement Activity A magazine, newsletter or online publication
Part Of Official Scheme? No
Geographic Reach Regional
Primary Audience Health professionals
Results and Impact LSEPS, Interview for SCOPE (Scientists on Public Engagement: from communication to deliberation), interviewee

N/A
Year(s) Of Engagement Activity 2009
 
Description Public Engagement Workshop - Wellcome Trust 
Form Of Engagement Activity Participation in an activity, workshop or similar
Part Of Official Scheme? No
Geographic Reach Local
Primary Audience Other academic audiences (collaborators, peers etc.)
Results and Impact sparked discussion of the issues facing regarding public engagement and how the Wellcome Trust could help to overcome difficulties or barriers.

n/a
Year(s) Of Engagement Activity 2013
 
Description Rachford Lecture - Cincinnati Children's Hospital 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Health professionals
Results and Impact Large question and answer session after the talk - talk promoted in depth discussions

n.a
Year(s) Of Engagement Activity 2013
 
Description Regenerative Medicine - a new frontier for therapeutic intervention, Cambridge 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Health professionals
Results and Impact The Society of Medicines Research, speaker

N/A
Year(s) Of Engagement Activity 2010
 
Description School visit, Edinburgh 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Schools
Results and Impact Presentation and discussion on stem cell, St George's School for Girls, presenter and discussion leader

N/A
Year(s) Of Engagement Activity 2007
 
Description School visit, London 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Schools
Results and Impact 800 A-level biology students attended a lecture on Stem Cell Research as part of their annual programme which is called 'A Student's Guide to DNA and Genetics'.

After providing a similar talk in 2009 The Institute of Education in London requested a return lecture.
Year(s) Of Engagement Activity 2009,2011
 
Description Science Summer School, Cambridge 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Schools
Results and Impact University of Cambridge Science Summer School, Guest Lecturer

N/A
Year(s) Of Engagement Activity 2006
 
Description Science Summer School, Cambridge 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Schools
Results and Impact University of Cambridge Science Summer School, Guest Lecturer

N/A
Year(s) Of Engagement Activity 2007
 
Description Science Summer School, Cambridge 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Schools
Results and Impact University of Cambridge Science Summer School, Guest Lecturer

N/A
Year(s) Of Engagement Activity 2008
 
Description Science Summer School, Cambridge 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Schools
Results and Impact University of Cambridge Science Summer School, Guest Lecturer

N/A
Year(s) Of Engagement Activity 2009
 
Description Science Talk 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Type Of Presentation Keynote/Invited Speaker
Geographic Reach Local
Primary Audience Public/other audiences
Results and Impact Public presentation on Stem Cells 'Hope or Hype' as part of the Cambridge Science Festival

n/a
Year(s) Of Engagement Activity 2013
 
Description Science in Society, Paris 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Public/other audiences
Results and Impact Ministere De Leenseignment Superieur, Science in Society

N/A
Year(s) Of Engagement Activity 2008
 
Description Science uncovered at the Natural History Museum 
Form Of Engagement Activity Participation in an activity, workshop or similar
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Public/other audiences
Results and Impact Masaki Kinsohita from the Smith Lab (Post doctoral researcher). For one evening only, the Natural History Museum will be taken over by scientists! Interactive activities and exhibits throughout the museum will provide an opportunity to learn about the latest research
Outcome: This activity contributes to our strategic objective to engage hard to reach adults
Year(s) Of Engagement Activity 2015
 
Description Speaker at 'See inside the Cambridge Stem Cell Institute' 2015 
Form Of Engagement Activity Participation in an open day or visit at my research institution
Part Of Official Scheme? No
Geographic Reach Local
Primary Audience Public/other audiences
Results and Impact 15 members of the general public were invited to the Stem Cell Institute for a tour of the facilities. Members of the Smith Lab showed the general public around the lab space and gave demonstrations about the different facilities we have on site. Austin Smith gave an introduction to the tour group about the Institute and also did a question and answer session at the end,
Year(s) Of Engagement Activity 2015
 
Description Staff Engagement Talks 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach Local
Primary Audience Other audiences
Results and Impact Research explained to the Admin team of the Cambridge Stem Cell Institute.
Year(s) Of Engagement Activity 2016
 
Description Stem Cell Podcast 
Form Of Engagement Activity A magazine, newsletter or online publication
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Other academic audiences (collaborators, peers etc.)
Results and Impact The interview was for the Stem Cell podcast which is listened to by more than 20,000. This was a great platform to discuss a recently published paper which allowed a wide audience to receive information about the paper.

Increase awareness of the published paper
Year(s) Of Engagement Activity 2014
 
Description Stem Cells and their Secrets, Cambridge 
Form Of Engagement Activity Participation in an activity, workshop or similar
Part Of Official Scheme? No
Geographic Reach Regional
Primary Audience Public/other audiences
Results and Impact JDRF Cambridge Open Day.

N/A
Year(s) Of Engagement Activity 2009
 
Description Talk Science, British Library, London 
Form Of Engagement Activity Participation in an activity, workshop or similar
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Health professionals
Results and Impact Presentation and discussion at the British Library, audience including researchers and scientific stakeholders

N/A
Year(s) Of Engagement Activity 2010
 
Description Talk to 6th Form Students, Canterbury 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach Local
Primary Audience Schools
Results and Impact Talk to 6th Form students, Simon Langton Grammar School for Boys, Speaker

N/A
Year(s) Of Engagement Activity 2009
 
Description Talk to Biomedical Students from Utrecht who were visiting the UK 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Schools
Results and Impact A group of 50 final year undergraduate and masters students interested in stem cell and regenerative medicine research

To give them and impression of stem cell and regenerative medical research work at an international university for making choice in their academic careers.
Year(s) Of Engagement Activity 2011
 
Description The layman challenge 'explaining work to a group of non-scientists' 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach Local
Primary Audience Public/other audiences
Results and Impact Professor Smith took part in the The layman challenge. He had to explain his work to a group of non-scientists, this was so the general public could understand his research without needing a scientific background.
Year(s) Of Engagement Activity 2015
 
Description Visit from MEP 
Form Of Engagement Activity Participation in an open day or visit at my research institution
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Policymakers/politicians
Results and Impact Vicky ford, MEP was interested in meeting to discuss the ECJ ruling on patents for Stem Cell Research

Ms Ford has asked for a follow-up meeting.
Year(s) Of Engagement Activity 2011
 
Description Youth Science Parliament, Cambridge 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach Regional
Primary Audience Schools
Results and Impact Presentation and discussion with 15-20 6th Form Students

N/A
Year(s) Of Engagement Activity 2010
 
Description interview in Vienna Standard newspaper 
Form Of Engagement Activity A press release, press conference or response to a media enquiry/interview
Part Of Official Scheme? No
Type Of Presentation Keynote/Invited Speaker
Geographic Reach Regional
Primary Audience Public/other audiences
Results and Impact interview in the Vienna Standard newspaper 3 July, 2013

n/a
Year(s) Of Engagement Activity 2013